Holen Sie sich die Stockscreener-App
14.44
7.44%
1.00
Handel nachbörslich:
14.39
-0.05
-0.35%
Finanzdaten der Denali Therapeutics Inc-Aktie (DNLI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
14.54
|
- | 1.267 | 294.12 | 35.14 |
Operating Expenses
|
0.24%
132.25
|
132.57 | 115.06 | 123.64 | 155.96 |
| Benefits Costs and Expenses |
116.34
|
- | - | - | - |
| Costs And Expenses |
0.24%
132.25
|
132.57 | 115.06 | 123.64 | 155.96 |
| Operating Income/Loss |
11.21%
-117.72
|
-132.57 | -113.80 | 170.48 | -120.81 |
| Income/Loss From Continuing Operations Before Tax |
-101.80
|
- | 1.267 | 294.12 | 35.14 |
| Income/Loss From Continuing Operations After Tax |
14.79%
-101.80
|
-119.47 | -99.35 | 183.38 | -109.78 |
|
Net Income/Loss
|
14.79%
-101.80
|
-119.47 | -99.35 | 183.38 | -109.78 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
50,597%
149.40
|
0.2947 | 137.64 | 137.05 | 136.52 |
| Diluted Average Shares |
50,597%
149.40
|
0.2947 | 137.64 | 140.93 | 136.52 |
| Basic Earnings Per Share |
21.84%
-0.68
|
-0.87 | -0.72 | 1.34 | -0.80 |
| Diluted Earnings Per Share |
21.84%
-0.68
|
-0.87 | -0.72 | 1.30 | -0.80 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):